ArticleMultiple sclerosis journal - experimental, translational and clinical

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.

T Derfuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.